Canary Speech is the leading AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Canary's vocal biomarker technology captures and analyzes speech data within seconds to identify irregularities in behavioral and cognitive changes before current clinical screening standards or noticeable symptoms for invisible illnesses like anxiety, depression and dementia.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/12/24 | $13,000,000 | Series A |
Cortes Capital Hackensack Meridian Health SMK Sorenson Communications | undisclosed |
